Ocular Therapeutix (OCUL) EBT Margin Growth (3y) (2017 - 2026)
Ocular Therapeutix (OCUL) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | -65,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65,750.00 |
| Dec 31, 2025 | -39,329.00 |
| Sep 30, 2025 | -27,465.00 |
| Jun 30, 2025 | -32,371.00 |
| Mar 31, 2025 | -44,174.00 |
| Dec 31, 2024 | -12,667.00 |
| Sep 30, 2024 | -10,818.00 |
| Jun 30, 2024 | -6,115.00 |
| Mar 31, 2024 | 2,299.00 |
| Dec 31, 2023 | 3,572.00 |
| Sep 30, 2023 | 12,536.00 |
| Jun 30, 2023 | 110,308.00 |
| Mar 31, 2023 | 51,645.00 |
| Dec 31, 2022 | 73,473.00 |
| Sep 30, 2022 | 322,576.00 |
| Jun 30, 2022 | 560,779.00 |
| Mar 31, 2022 | 662,369.00 |
| Dec 31, 2021 | 324,749.00 |
| Sep 30, 2021 | 283,978.00 |
| Jun 30, 2021 | 194,354.00 |